Skip to main content
. 2014 Jul 10;9:153. doi: 10.1186/1748-717X-9-153

Table 5.

Comparison between IMRT and VMAT for 39 head and neck plans with a prescription of 69.3 Gy

  IMRT (n = 38) 1A (n = 38) 1Am (n = 38) 2A (n = 38) 2Am (n = 38)
PTV 69.3Gy
 
 
 
 
 
Dmax (%)
107.6 (103.9 - 110.3)
107.9 (104.4 - 112.7)b+
108.0 (105.7-111.8)ac+
106.8 (104.4- 109.2)a+b+
107.0 (104.4 - 109.9)c+
V95% (%)
93.4 (88.1 - 97.8)
91.5 (85.3 - 99.1)a+
91.0 (82.9 - 98.1)a+c
91.9 (86.1 - 99.1)a+
91.6 (85.4 - 98.8)a+c
HI
1.10 (1.07 - 1.14)
1.11 (1.06 - 1.15)a+b+
1.12 (1.07 - 1.17)a+c+
1.10 (1.06 - 1.14)b+
1.11 (1.06 - 1.14)c+
CN
0.77 (0.22 - 0.91)
0.81 (0.26 - 0.91)a+b+
0.83 (0.30 - 0.92)a+c+
0.84 (0.29 - 0.93)a+b+
0.85 (0.40 - 0.93)a+c+
PTV 56.1Gy
 
 
 
 
 
Dmax (%)
127.8 (124.0 - 135.1)
122.7 (115.6 - 130.4)a+
123.2 (116.7-129.0)a+c+
122.3 (117.0 - 126.4)a+
122.1 (118.2-127.2)a+c+
V95% (%)
93.1 (81.7 - 97.9)
93.3 (85.5 - 97.3)b+
87.6 (80.3 - 94.9)a+c+
96.1 (92.2 - 99.1)a+b+
92.0 (84.1 - 97.2)c+
HI
1.21 (1.12 - 1.31)
1.19 (1.14 - 1.24)ab+
1.21 (1.14 - 1.28)c+
1.16 (1.10 - 1.22)a+b+
1.18 (1.10 - 1.25)a+c+
CN
0.67 (0.46 - 0.82)
0.69 (0.42 - 0.83)b+
0.69 (0.49 - 0.81)c+
0.71 (0.44 - 0.85)a+b+
0.73 (0.50 - 0.85)a+c+
D50% (%)
101.2 (99.0 - 104.3)
102.6 (101.1-105.9)a+b+
100.8 (99.5 - 102.1)
102.2 (101.0 -104.6)a+b+
100.6 (98.9 - 101.9)a
PTV 54Gy
 
 
 
 
 
Dmax (%)
129.9 (106.5 - 136.3)
126.8 (114.5 - 134.6)ab+
126.8 (112.5 - 133.0)a
124.5 (110.7 -129.8)a+b+
125.6 (109.1 - 132.9)a+
V95% (%)
90.1 (85.0 - 95.3)
94.0 (90.8 - 97.5)a+b+
89.0 (79.2 - 92.9)
96.1 (92.5 - 98.7)a+b+
92.5 (87.3 - 97.5)
HI
1.22 (1.09 - 1.28)
1.20 (1.12 - 1.25)b+
1.21 (1.12 - 1.31)c+
1.17 (1.09 - 1.24)a+b+
1.19 (1.09 - 1.27)a+c+
CN
0.70 (0.57 - 0.79)
0.73 (0.63 - 0.87)a+b+
0.74 (0.65 - 0.81)a+
0.76 (0.66 - 0.88)a+b+
0.76 (0.65 - 0.87)a+
D50% (%)
100.1 (98.4 - 101.5)
102.4 (101.3-103.4)a+b+
100.6 (98.9 - 102.2)
101.9 (101.1- 103.2)a+b+
100.5 (99.8 - 101.8)
PTV 52.8Gy
 
 
 
 
 
Dmax (%)
114.0 (103.9 - 134.7)
114.9 (109.6 - 128.2)b+
112.9 (108.0 - 126.5)
113.1 (109.1 - 127.3)b+
112.0 (106.2 - 128.3)
V95% (%)
92.7 (73.0 - 99.5)
96.5 (91.7 - 99.3)ab+
91.9 (83.8 - 97.9)c+
97.9 (95.5 - 99.8)a+b+
95.1 (87.1 - 99.2)c+
HI
1.11 (1.07 - 1.21)
1.13 (1.09 - 1.18)b+
1.13 (1.09 - 1.18)c+
1.10 (1.07 - 1.14)b+
1.11 (1.07 - 1.15)c+
CN
0.64 (0.47 - 0.75)
0.71 (0.63 - 0.84)a+
0.72 (0.64 - 0.87)a+c
0.72 (0.64 - 0.84)a+
0.74 (0.63 - 0.88)a+c
D50% (%)
99.9 (98.0 - 102.7)
102.7 (101.5-104.5)a+b+
100.5 (99.5 - 101.5)
102.2 (101.0 -103.6)a+b+
100.5 (99.1 - 101.8)
Body
 
 
 
 
 
Dmean (Gy)
7.1 (3.9 - 18.2)
6.7 (3.7 - 17.0)a+
6.6 (3.6 - 16.8)a+c+
6.7 (3.7 - 17.0)a+
6.6 (3.6 - 16.6)a+c+
V5Gy (%)
21.2 (10.6 - 56.6)
21.4 (10.7 - 58.2)a+b+
21.4 (10.7 - 57.5)a+c+
21.6 (10.7 - 58.5)a+b+
21.5 (10.8 - 58.7)a+c+
Brain
 
 
 
 
 
Dmax (Gy)
38.8 (3.7 - 62.9)
41.5 (5.2 - 60.4)ab
40.1 (5.1 - 58.6)
40.1 (5.2 - 63.3)b
39.9 (5.0 - 60.7)
Brain stem
 
 
 
 
 
Dmax (Gy)
39.3 (20.6 - 51.0)
44.6 (22.2 - 51.5)a+
42.9 (18.9 - 52.5)a
44.3 (15.0 - 51.6)a+
43.1 (17.0 - 51.0)a
Lips
 
 
 
 
 
Dmax (Gy)
28.6 (2.1 - 71.4)
29.1 (2.4 - 70.4)
28.3 (2.2 - 64.7)
30.4 (2.2 - 70.3)
29.8 (2.2 - 69.3)
Parotid gland
 
 
 
 
 
Dmean (Gy)
30.2 (7.8 - 62.7)
30.7 (9.7 - 55.7)a+b+
29.5 (9.7 - 55.8)
30.3 (9.6 - 55.7)ab+
29.2 (9.8 - 56.0)
V28Gy (%)
48.1 (8.7 - 100.0)
49.6 (11.0 - 92.9)a+b+
46.6 (12.1 - 93.0)
48.2 (10.3 - 93.2)ab+
45.6 (10.4 - 93.3)
Spine
 
 
 
 
 
Dmax (Gy)
37.4 (33.1 - 44.3)
36.3 (33.2 - 44.6)ab+
36.1 (32.7 - 44.0)ac+
35.1 (32.5 - 41.0)a+b+
35.3 (32.6 - 42.8)a+c+
MU 649.2 (458–802) 370.5 (313–524)a+b+ 372.9 (326–482)a+c+ 393.1 (322–558)a+b+ 393.6 (320–538)a+c+

Single and double arc plans before (1A, 2A) and after modification (1Am, 2Am) of the optimization penalties; values are expressed as the mean (range).

ap < 0.05 for Wilcoxon matched-pair signed rank test vs. IMRT; bp < 0.05 1A vs. 2A; cp < 0.05 1Am vs. 2Am; +p < 0.01.